The dissociation constant (K d ) is indicated.
In our GST pull-down assays, we found that the amounts of the full-length Rab9A and Rab9B (residues 1-201) bound to GST-tagged RUTBC2 RBD (residues 254-425) on the glutathione-coated resin were more than 1:1 molar ratio, whereas the amounts of the C-terminal hypervariable region truncated Rab9AΔC and Rab9BΔC (residues 1-171) bound to GST-tagged RUTBC2 RBD were about 1:1 molar ratio ( Figure S3A ). Our gel filtration analyses of the full-length Rab9A/Rab9B show that there are a major elution peak with an apparent molecular mass of about 30 kDa and a minor elution peak with an apparent molecular mass of about 75 kDa ( Figure S3B, upper panels) . Dynamic light scattering analyses of the protein samples collected from these two peaks exhibit molecular masses of about 37 kDa and 71 kDa, which appear to correspond to a monomer and a dimer, respectively (data not shown). However, the gel filtration analyses of Rab9AΔC and Rab9BΔC show mainly one elution peak with an apparent molecular mass of about 25 kDa corresponding to a monomer ( Figure S3B, upper panels) . Intriguingly, when we removed the two C-terminal cysteines, the purified Rab9A and Rab9B (residues 1-199) also exist as a monomer as shown by both gel filtration analyses ( Figure S3B , upper panels) and DLS analyses (data not shown). The GST pull-down assays show that the amounts of the C-terminal cysteine truncated Rab9A and Rab9B bound to GST-tagged RUTBC2 RBD was about 1:1 molar ratio ( Figure S3A) . Furthermore, addition of 20 mM dithiothreitol (DTT) can dramatically alleviate the dimerization of the full-length Rab9A/Rab9B ( Figure   S3B , lower panels). Consistently, our ITC analysis result shows that the K d value of the full-length Rab9A with RUTBC2 RBD is 0.77±0.10 µM (Figure S3C) , which is comparable to that of the C-terminal cysteine truncated Rab9A (0.32±0.08 µM) and that of the C-terminal region truncated Rab9AΔC (0.39±0.07 µM) ( Figure 4B ).
These results indicate that the full-length Rab9A/Rab9B is partially dimerized in solution probably due to formation of a disulfide bond between the C-terminal cysteines.
The partial dimerization of the full-length Rab9A/Rab9B could make their amounts bound to RUTBC2 RBD in more than 1:1 molar ratio in the GST pull-down assays although it does not affect the binding with RUTBC2 RBD. Thus, to avoid possible artifact in the amount of Rab9A/Rab9B bound to GST-tagged RUTBC2 RBD due to the partial dimerization of Rab9A/Rab9B in the GST pull-down assays, we used the cysteine deletion form (residues 1-199) of Rab9A/Rab9B to analyze their binding abilities with RUTBC2
RBD. In addition, we have also added 1 mM DTT in the GST pull-down assays. Exo84 uses the β5-β6 strands and α1 helix to interact with RalA (Jin et al., 2005) ; in the Rac2-PLC-γ2 complex (PDB code 2W2X), PLC-γ2 uses the β5-β6 loop and α1 helix to interact with Rac2 (Bunney et al., 2009) ; in the RhoA-PRG complex (PDB code 3KZ1), PRG uses the β5-β7 strands to interact with RhoA (Chen et al., 2010) ; in the Arf1-ARHGAP21 complex (PDB code 2J59), ARHGAP21 uses the β5 strand, the β5-β6
loop and a C-terminal α helix to interact with Arf1 (Menetrey et al., 2007) ; in the Arf6-Grp1 complex (PDB code 4KAX), Grp1 uses the β3-β4 strands and the βi1-βi2 insertion to interact with Arf6 (Malaby et al., 2013) ; in the Ran-RanBD1 complex (PDB code 1RRP), RanBD1 uses the N-terminal loop, the β2 strand, the β3-β4 loop, and the β6-β7 strands to interact with Ran (Vetter et al., 1999) ; in the Rac1-PLC-β2 complex (PDB code 2FJU), PLC-β2 uses the β1-β2 strands and three loops to interact with Rac1 (Jezyk et al., 2006) ; and in the Rab9A-RUTBC2 RBD complex, RUTBC2 RBD uses mainly the β1 strand and the η1 insertion to interact with Rab9A. The switch I, interswitch, and switch II regions, and the CDRs of Rab GTPases are colored in magenta, yellow, cyan, and orange, respectively, and the rest is colored in gray. The effectors are shown in green with the binding sites highlighted in red. In the Rab3-Rabphilin-3A complex (PDB code 1ZBD), Rabphilin-3A uses mainly a long α-helix to interact with the switch/interswtich regions of Rab3. Meanwhile, the CDRs also participate in their interactions (Ostermeier and Brunger, 1999) . In the Rab4-Rabenosyn-5 (PDB code 1Z0K) and Rab5-Rabaptin-5 (PDB code 1TU3) complexes, the effectors use a coiled coil core to bind their respective Rabs with 1:1 or 2:2 Rab-effector binding stoichiometries (Eathiraj et al., 2005; Zhu et al., 2004) . In the Rab8-OCRL1 (PDB code 3QBT) (Hou et al., 2011) , Rab5-EEA1 (PDB code 3MJH) (Mishra et al., 2010) , and Rab9A-RUTBC2 RBD complexes, the effectors interact with their Rabs mainly via a β-strand and an α-helix but in different ways.
